MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CRNX has $1,126,257K in assets. $134,174K in debts. $101,536K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1232.30%
Quick Ratio
1229.92%
Cash Ratio
119.35%
Debt to Asset Ratio
11.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investment securities, amortized...
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Common stock and paid-in capital...
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
101,536
Restricted cash
0
Investment securities, amortized cost of 924,317 at december 31, 2025 and 1,088,561 at december 31, 2024
926,353
Trade accounts receivable, net
592
Inventory
2,022
Prepaid expenses and other current assets
17,839
Total current assets
1,048,342
Property and equipment, net
14,296
Operating lease right-of-use assets
40,492
Restricted cash, net of current portion
800
Prepaid expenses and other assets, net of current portion
22,327
Total assets
1,126,257
Accounts payable and accrued expenses
41,770
Accrued compensation and related expenses
35,578
Deferred revenue
1,235
Operating lease liabilities
6,489
Total current liabilities
85,072
Operating lease liabilities, non-current
42,052
Deferred revenue, non-current
3,810
Other non-current liabilities
3,240
Total liabilities
134,174
Common stock and paid-in capital, 0.001 par 200,000 shares authorized, 92,926 shares issued and outstanding at december 31, 2025 68,175 shares issued and outstanding at december 31, 2024
2,407,757
Accumulated other comprehensive income
1,865
Accumulated deficit
-1,417,427
Stock held in trust
112
Total stockholders equity
992,083
Total liabilities and stockholders equity
1,126,257
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment securities,amortized cost of 924,317...$926,353K Cash and cashequivalents$101,536K Prepaid expenses andother current assets$17,839K Inventory$2,022K Trade accountsreceivable, net$592K Total current assets$1,048,342K Operating leaseright-of-use assets$40,492K Prepaid expenses andother assets, net of...$22,327K Property and equipment,net$14,296K Restricted cash, net ofcurrent portion$800K Total assets$1,126,257K Total liabilities andstockholders equity$1,126,257K Total stockholdersequity$992,083K Total liabilities$134,174K Accumulated deficit-$1,417,427K Stock held in trust$112K Common stock andpaid-in capital, 0.001...$2,407,757K Total currentliabilities$85,072K Operating leaseliabilities, non-current$42,052K Deferred revenue,non-current$3,810K Other non-currentliabilities$3,240K Accumulated othercomprehensive income$1,865K Accounts payable andaccrued expenses$41,770K Accrued compensationand related...$35,578K Operating leaseliabilities$6,489K Deferred revenue$1,235K

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)